ATLANTA & OSAKA, Japan--(BUSINESS WIRE)--On October 9, 2008, Shionogi & Co., Ltd. (“Shionogi”) and Sciele Pharma, Inc. (“Sciele”) (NASDAQ: SCRX) announced the successful completion of the cash tender offer by Shionogi’s indirect wholly owned subsidiary, Tall Bridge, Inc. (“Purchaser”), to acquire all outstanding shares of common stock of Sciele for $31.00 per share. The subsequent offering period for the tender offer expired at 5:00 p.m., New York City time, on Wednesday, October 8, 2008. The depositary for the tender offer has advised Shionogi that, as of the expiration of the subsequent offering period, a total of approximately 29,758,788 shares were validly tendered in the offering period, representing approximately 92.0% of all outstanding shares of Sciele. Purchaser has accepted for payment all shares that were validly tendered and not withdrawn during the offering period, and payment for such shares has or will be made promptly, in accordance with the terms of the tender offer.
